Loading clinical trials...
Loading clinical trials...
Mitral valve prolapse (MVP) affects up to 3% of the general population and a small subset of patients is at risk for ventricular arrhythmias. This subgroup is referred to as AMVP (arrhythmic MVP) and ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT07384871 · Mitral Valve Prolapse, Myxomatous Mitral Valve Degeneration
NCT07196397 · Vasovagal Syndrome VVS, Cardioinhibitory Carotid Sinus Syndrome CSS, and more
NCT06255457 · Mitral Regurgitation, Mitral Valve Prolapse, and more
NCT07103733 · Mitral Valve Prolapse, Left Ventricular Fibrosis, and more
NCT06889662 · Myocarditis, Ventricular Arrythmia
UZ Leuven
Leuven, Vlaams-Brabant
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions